Cargando…

Phenotypes of Psoriasis in Patients in Need of Systemic Treatment, and Correlation with Personal Habits, Treatment History and Comorbidities: A Cross-sectional Latent Class Analysis of Data from the Italian PsoReal Registry

Detalles Bibliográficos
Autores principales:	CAZZANIGA, Simone, HEIDEMEYER, Kristine, NALDI, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158830/ https://www.ncbi.nlm.nih.gov/pubmed/37014266 http://dx.doi.org/10.2340/actadv.v103.5331

Ejemplares similares

Nail psoriasis as a severity indicator: results from the PsoReal study
por: Radtke, Marc A, et al.
Publicado: (2010)

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
por: Reich, K., et al.
Publicado: (2015)

Comorbidity profiles of psoriasis in Taiwan: A latent class analysis
por: Wu, Chen-Yi, et al.
Publicado: (2018)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
por: Heidemeyer, Kristine, et al.
Publicado: (2023)

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Long-Term Dose Optimization of Adalimumab via Dose Spacing in Patients with Psoriasis
por: Benzaquen, Michael, et al.
Publicado: (2022)

Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
por: Emelianov, Vladimir, et al.
Publicado: (2021)

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)
por: Narcisi, Alessandra, et al.
Publicado: (2022)

Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
por: Lambert, J.L.W., et al.
Publicado: (2020)

Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
por: Graier, T., et al.
Publicado: (2022)

Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis
por: HEWITT, Rachael M., et al.
Publicado: (2021)

Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence
por: Piaserico, Stefano, et al.
Publicado: (2022)

Treatment with secukinumab for plaque psoriasis in patients with infectious comorbidities and latent tuberculosis: A multi‐case report analysis
por: Fiorella, Carmen
Publicado: (2022)

Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
por: Li, Shan-Shan, et al.
Publicado: (2022)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Mercuri, Santo Raffaele, et al.
Publicado: (2010)

Psoriasis comorbidities: complications and benefits of immunobiological treatment
por: de Carvalho, André Vicente Esteves, et al.
Publicado: (2016)

Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)
por: Lambert, J.L.W., et al.
Publicado: (2020)

Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
por: Piaserico, Stefano, et al.
Publicado: (2020)

Classification of comorbidity in obsessive–compulsive disorder: A latent class analysis
por: van Oudheusden, Lucas J. B., et al.
Publicado: (2020)

Comorbidity profiles of patients experiencing homelessness: A latent class analysis
por: Subedi, Keshab, et al.
Publicado: (2022)

Treatment Satisfaction Among Bahraini Patients With Psoriasis: A Single Center Cross-Sectional Study Using the PsoSat Questionnaire
por: Ali, Mahmood, et al.
Publicado: (2023)

Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso
por: Wellmann, Phoebe, et al.
Publicado: (2022)

Psoriasis: Comorbidities
por: Yamazaki, Fumikazu
Publicado: (2021)

Identification of bronchiolitis profiles in Italian children through the application of latent class analysis
por: Ferrante, Giuliana, et al.
Publicado: (2020)

Successful Treatment of Iatrogenic Cutaneous Siderosis with Pigment Lasers: A Retrospective Study in 15 Consecutive Patients
por: HEIDEMEYER, Kristine, et al.
Publicado: (2020)

Investigation of comorbidities of COVID-19 patients with hepatosteatosis using latent class analysis
por: Pasin, Ozge, et al.
Publicado: (2022)

Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs
por: Gisondi, Paolo, et al.
Publicado: (2021)

Identifying the pattern of unhealthy dietary habits among an Iranian population: A latent class analysis
por: Gholami, Ali, et al.
Publicado: (2018)

Psoriasis pathogenesis – Pso p27 constitutes a compact structure forming large aggregates
por: Lysvand, Hilde, et al.
Publicado: (2015)

CoronaBest und PsoBest Bioscience: Neue Ausbaustufen beim Deutschen Psoriasis-Register
por: Gehoff, Mario
Publicado: (2020)

Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study
por: VESIKANSA, Aino, et al.
Publicado: (2023)

Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
por: Gisondi, Paolo, et al.
Publicado: (2021)

How ‘core’ are motor timing difficulties in ADHD? A latent class comparison of pure and comorbid ADHD classes
por: van der Meer, Jolanda M. J., et al.
Publicado: (2015)

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study
por: Hong, C‐H., et al.
Publicado: (2017)

Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis
por: Zemedikun, Dawit T., et al.
Publicado: (2022)

Psoriasis and smoking: links and risks
por: Naldi, Luigi
Publicado: (2016)

Psoriasis: new comorbidities
por: Machado-Pinto, Jackson, et al.
Publicado: (2016)

Comorbidity in Men with Psoriasis
por: Salihbegovic, Eldina Malkic, et al.
Publicado: (2021)

Apremilast for treatment of recalcitrant aphthous stomatitis
por: Schibler, Fabian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jq63bf6uo0iiiaci6ttdl281hk